The press release will be available in the Investors section of Cellectis’ website: Cellectis will not host a conference call to discuss these results. Our investors relations team remains available ...

Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that the company has ...

The collaboration will progress under the combined company, NewCelX, upon completion of the anticipated merger ZURICH and NESS ZIONA, Israel, Oct. 27, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (Nasd ...

The collaboration will progress under the combined company, NewCelX, upon completion of the anticipated merger ZURICH and NESS ZIONA, Israel, Oct. 27, 2025 /PRNewswire/ -- NLS Pharmaceutics ...

Title: Cibus, Inc. Third Quarter 2025 Results Conference Call Event Date: Thursday, November 13, 2025 Time: 4:30 p.m. ET Participant Numbers: +1-800-274-8461 (U.S.), +1-203-518-9814 (International) ...

Press Democrat readers share their thoughts on the president, the federal shutdown, resistance movements and Democrats ...

After two days full of live demos and pitches, it's time to announce the five finalists at this year's Startup Battlefield.

Mary E. Brunkow Ph.D., a 1983 graduate of UW who now works in Seattle, won the Nobel Prize in Physiology or Medicine. News of ...

Overview of Epigenetics MarketThe global Epigenetics Market is valued at USD 2.56 Billion in 2024 and is projected to reach a value of USD 9.11 Billion by 2035 at a CAGR (Compound Annual Growth Rate) ...

One day after ordering the Trump administration to continue funding food stamps during the shutdown, a federal court gave the government a choice. It can either make full payments by Monday, or ...

He helmed memorable episodes spotlighting Leonard Nimoy and Ellen Corby on those shows, plus the three-part pilot for ...

There has been an endless “war” between pathogen organisms armed with the ability to establish new, genetically based ...